chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Just to let you know the side effects of the vaccine that I experienced and am slowly getting over?.. 1} Sore arm   ---lasted 4 days ---not now 2} Itchy arm ? with three small holes around the injection site now from the itchiness   ---starting to scab over 3} A little swollen arm  ---lasted 4 days ---not now 4} Headache to migraine   --- migraine lasted 4 days ---now slight headache only 5} Bending over, down or moving quickly made me dizzy and my head hurt more   ---not really now, only the bending down to long causes a throbbing in my head 6} Kind of foggy in mind and sight  ---lasted 4 days ---not now 7}Short of breath ? which I still have   ---still have   ---this one has me really worried I enjoy the outdoors and being active with hiking and more what problems will this cause me 8} Cough from the short or breath   ---if I do too much 9} Nauseous and vomiting  lasted 2 days ---now there is no vomit only nauseous 10} Body hurts  ---lasted 4 days ---not now 11} Temp change to feeling hotter without a temp, between 97.0-98.0 once was 95.9   ---I still feel warm even turned my house thermostat down to 67-68---   still 12} felt like there was lead in my feet when walking hard to move   ---lasted 4 days   ---not now 13} tired only wanted to rest or sleep   ---lasted 4 days   ---still tired but not like it was  I know I was told this cannot be from the vaccine, I will guarantee that it is. Not one of these were present or an issue until I had the vaccine.  There may be more common ones people have listed and reported, but not everyone reacts to the vaccine the same and some are more severe than others.  All side effects should and must be acknowledged for any possibility of future problems or complications.  I did give this information to clinic worker, and she had me come in for a covid test {letting me know my shortness of breath and hard to breathe cannot be part of the vaccine} and the two tests came in as negative. Anything is possible and should not be disregarded, like I said no two people are alike.  Still having SOB which worsens with talking and activity
extreme body aches, fever, chills, arm very swollen at injection site , severe headaches, sensitive to light
Menstrual bleeding.; Horrible headache.; This is a spontaneous report from a contactable consumer (Patient) or other non health care professional. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH mRNA COVID-19 VACCINE, solution for injection, Lot Number: EW0198 ), dose 1 intramuscular on 25Jun2021 at 11:35 AM as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient did not have other vaccinations prior to 4 weeks of COVID vaccine. The patient experienced horrible headache on 27Jun2021. and she had menstrual bleeding on 28Jun2021. Patient reported that menstrual bleeding stopped and she haven't any bleeding that day so it's just yesterday. The outcome of the event menstrual bleeding was recovered on 28Jun2021 and the outcome of horrible headache was unknown.
Information has been received from a physician concerning a 15 year old female patient who was vaccinated IM with a 0.5 mL dose of GARDASIL (lot # not provided). Concomitant therapies included hepatitis B virus vaccine (manufacturer unknown, lot # not provided) and TDAP (manufacturer unknown, lot # not provided). Subsequently, 2-3 days after the vaccines, the patient experienced stomach pain, nausea and vomiting. The patient sought unspecified medical attention. The patient recovered on an unspecified date. Additional information has been requested. This is one of two reports from the same source (WAES0807USA05655).
contracted Covid after getting the vaccine; contracted Covid after getting the vaccine; This is a spontaneous report from a contactable consumer. This consumer reported similar events for two patients. This is the second of two reports.   A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not provided), via an unspecified route of administration on an unspecified date at dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The reporter mentioned that she knew someone who a contracted COVID on an unspecified date after getting the vaccine. The outcome of the events was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101310883 same reporter and drug, similar event, different patients
Case number PHEH2014US018227, is an initial spontaneous report from the health care professional (medical assistant) received on 08 Sep 2014. This report refers to a 16-year-old female patient. Past medical history and concomitant medication were not provided. She was vaccinated with 0.5 ml of MENVEO (batch number: unknown) intramuscularly on 05 Sep 2014. It was reported that the MENVEO received by the patient had been at 47 Fahrenheit (F) for 10 minutes on 29 Aug 2014. No adverse event reported following this medication error (incorrect storage of drug). No additional information was available.
p/vax pt has noticed a small (0.5cm diameter) subdermal/dermal firm area where vax given
Submitted per patient request- Pt presents to the clinic today for a rash to left arm. She reports that she had a Pfizer booster in May. She had previously not had a reaction. This was her fourth dose. She did have COVID-19 in August. She noticed the rash presented to the left side of the arm where she received her shot at the beginning of September. Denies any changes to soaps detergents, exposure to plants, environmental changes, or pain to the site. She states that it has decreased in size/ redness and has improved. Denies any fevers, chills, swelling, drainage or pustules, to the arm, hives, or systemic reaction, lymphadenopathy or changes in sensation. She is well today otherwise, just wants to be sure that she is OK and make sure that it is reported as a reaction. Does have a derm that she sees. Will send him a copy of this report and we will follow her reaction. Denies any systemic reaction after she received her last dose or any other doses. She has been using hydrocortisone OTC for her symptoms.
Vibrating sensations in nerves of arms and legs and pelvis - tremor in left arm. Slight urinary/fecal incontinence, dizziness, vertigo that comes and goes. Elevated and low body temperature at times.  3/20/07 Received medical records from hospital/clinic which reveal patient experienced left arm tremor for approx 3 wks before neuro eval on 12/14/06 which occurred mostly at rest.  She had continued pain & muscle spasms of left anterior thigh where received dog bite on 9/6/06.  PT was helping including US therapy. Exam on initial eval revealed well healed & no longer visible bite on left thigh.  Neuro findings were as follows: no peripheral neuropathy.  Referred for MRI of brain & spine; ID for rabies w/u; & possible EMG/NCS Next neuro vs on 12/27/06 revealed improved LLE but vibrating sensation of RLE & RUE for approx 6 days.  Still had leg spasms.  Next vs was 1/10/07 to neuro clinic w/continued neuro s/s including vibration of RUE, abd & RLE & tremors of LUE.  Now w/complaints of dizziness or los of balance.  Exam at that time revealed slight tremor or myoclonic jerking of LUE at rest.  Reflexes & strength OK.  Dx at that time was ill defined neuro sys which might or might not be vax related but definitely felt to not be rabies.  CDC & State Rabies office were contacted.  Scheduled for EMG/NCS & further neuro f/u.  FINAL DX: None provided. Muscle cramping  Vibrating sensations  Slight incontinence
About 45 minutes after my injection, I started having a red rash on my chest and under breasts. covered the whole area underneath my breasts and on under side.  Went to Doctor  next day ,  who advised it was a reaction. Day . Day 4 (04/22/2021) - rash has spread to my lower stomach area and around to my sides\. Also is starting to itch
temperature went up just a little bit but not a lot; chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (temperature went up just a little bit but not a lot) and CHILLS (chills) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (temperature went up just a little bit but not a lot) and CHILLS (chills). At the time of the report, PYREXIA (temperature went up just a little bit but not a lot) had resolved and CHILLS (chills) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: high (High) 99.5.         No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD21-054356 (Patient Link).   Reporter did not allow further contact
TPC placed to patient to follow up on email that was sent on 10/31/21 for covid vaccine reaction. Patient reports that he received the J & J Covid vaccine at on 10/29/21. He developed hives within 15 minutes of vaccine administration. He was given benadryl onsite by the pharmacist. Patient c/o 103 fever and body aches. He reports that the hives lasted on/off x 2 days that resolved with benadryl and Pepcid. Today, he c/o muscle pain and low grade fever. Denies chest pain, difficulty swallowing, rash or shortness of breath.
Mild skin irritations mid April 21. Hives, fever and joint pains mid-May 21. Very high inflammation levels mid-May 21. These are all symptoms of my auto-immune disease that was in remission for 6 years. Many tests of potential causes mid-May-end of June 21. No positive results found.
Vaccine was administered outside of recommended storage guidelines--it was frozen under normal temperatures, not ultra-cold temperatures, then thawed for administration. Per Pfizer stability data the vaccine is still safe and effective for up to 14 days under these conditions, but the use is considered off label.
This patient was on active duty to Guatemala 01/05/01 10 02/18/01. Started on Primaguine, Monday 02/19/01. On Tuesday, 02/20/01, the patient noticed redness to his hands. On Saturday 02/24/2001, a typical rash covering his entire body. Edema +3, to lower extremities. The patient was treated at a civilian ER on 02/25/01.
Patient (mother) reports staph infection at injection site (R) thigh. Mother states problem is resolved and was treated by physician.
I know he has to have it with in three days of testing positive; I know he has to have it with in three days of testing positive; booster; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non healthcare professional). The reporter is the parent. Other Case identifier(s): 202101789414 (1).  A male patient received bnt162b2 (BNT162B2), administration date 26Nov2021 (Batch/Lot number: unknown) as DOSE 3 (BOOSTER), SINGLE (Batch/Lot number: unknown) as DOSE 2, SINGLE and (Batch/Lot number: unknown) as DOSE 1, SINGLE for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: IMMUNISATION (medically significant) with onset 26Nov2021, outcome "unknown", described as "booster"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Dec2021, outcome "unknown" and all described as "I know he has to have it with in three days of testing positive". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (Dec2021) positive.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101789414 same reporter/patient/product, different dose/event.
right deltoid immediately swelled once flu vaccine was administered. ice pack given/applied. (The pt) released to go home. Swelling reduced.
had extreme heat & pain lt arm, shoulder & neck, h/a, acid metallic taste in mouth;dizziness then tightness in chest 1hr later & nausea;
Became pale and nauseated. Wanted to lay down. Never lost consciousness. Last about 5 min. VSS at HR-71-22-97/54.
In December 1999, the pt developed five lesions on her face. The reporter described the lesions as dots on her face. The reporter was instructed to contact the pt's physician. At the time of the reporting, the pt's skin lesions persisted.
PT DEVELOPED COUGH, SORE THROAT, RUNNY NOSE, AND BODY ACHES - BUT NO FEVER.   LASTED 4 DAYS AND IS RESOLVED.
Deep vein thrombosis left leg, Lovenox f/by Pradexa. On 5/28/21, received pfizer covid vaccine 2nd dose.  On 5/29, visited . on 6/1/21, noted Lf leg pain. 10 days later, noted severe pain and swelling. ED visit on 6/11/21
Pt aged 12yrs received the Pfizer Ped Vaccine for age 5-11yrs instead of the Pfizer 12yrs+ vaccine. No adverse event reported
A nurse reported that a child received an injection of Prevnar. Five to six days post vaccination, the child developed a generalized rash. No further info was available at the date of this report.
her HCP told her not to get the second vaccine; Left leg pain; Weakness; This case was reported by a consumer via call center representative and described the occurrence of leg pain in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In December 2021, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, 20 hrs after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced leg pain, weakness and incomplete course of vaccination. The patient was treated with meloxicam (Mobic). On an unknown date, the outcome of the leg pain and weakness were recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the leg pain and weakness to be related to Shingrix.     Additional Information: GSK Receipt date: 28-APR-2022 Reporters comment: The patient self-reported the case. The patient received 1st dose of Shingrix in left arm. After receiving Shingrix, the patient was started with left leg pain and weakness. The patient stated that, her healthcare professional told her not to get the 2nd dose of Shingrix. The reporter did not consent to follow-up. No healthcare professional for follow up. Additional supportive information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete vaccination schedule.
Hot, red, swollen upper left arm. DTAP - IPV - VARIVAX given on 1/24/12. Prescription for KEFLEX.
Her left breast felt much larger than her right breast; Soreness at the injection site; headache; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.A 49 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 27Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 28Feb2021, outcome "unknown", described as "Soreness at the injection site"; HEADACHE (non-serious) with onset 28Feb2021, outcome "unknown", described as "headache"; BREAST DISORDER (non-serious) with onset Mar2021, outcome "unknown", described as "Her left breast felt much larger than her right breast". Therapeutic measures were taken as a result of headache. Additional information: Reporter states that patient had soreness at the injection site and a headache the next morning. Tylenol took care of the headache. The patient said that her left breast has always been a bit larger than her right breast but the difference on 01Mar or 02Mar day was "insane" as she describes it. Her left breast felt much larger than her right breast. She was vaccinated in her left arm. No pain. She said it could also be because she is getting her period. Advised her to call her doctor. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
PATIENT WOKE UP DIZZY WITH A MILD FEVER AND NOT ABLE TO MAINTAIN BALANCE, FEELING GENERALLY AWFUL
AT SITE OF INJECTION DEVELOPED A ROUND CIRCLE INCREASED TO A SIZE OF SILVER DOLLAR AND HOT TO TOUCH.  CURRENTLY  DOUBLE SIZE OF SILVER ,SORE, AND HOT
I was given the vaccine approx 20 minutes later started feeling pain in stomach that radiated to back.  This continued to worsen then I started vomiting. I think about 12:00 I went to Urgent Care and then was recommended to go to Medical Center. I was fine until I was given the shot.  I had to go to Medical Center and was dx with pancreatitis and then went into afib  I had no previous history of Afib or pancreatitis.   The doctors said they have not found any cases where that Shingirx could cause such a reaction unless I could be the first to have one to this degree.  There always has to be a first.  I have found a paper that Varicella has caused pancreatitis in a 44 year old women due to the close relationship of the two vaccine that it seems feasible that  Shingirx could also produce same reaction.  I just want something on record in case this ever happens again to someone else.
The patient developed pleuritic chest pain 1 day after receiving 2nd COVID vaccination with mRNA Pfizer vaccine.  We are treating her for presumed pericarditis that is mild.
pt recvd vax;3-4 days later devel ache in groin,general aches & pains,low grade t;all exams w/in nl limits;referred to urologist since sxs persist;
SECOND DOSE IS MORE THAN 42 DAYS FROM FIRST DOSE WHICH IS 12/22/2021
Information has been received from a physician concerning a 6 year old male who on 05Apr1998 was vaccinated with varicella virus vaccine live.  On 22Apr04 it was reported that the pt came in early this week with just a few pox and came back yesterday with a moderate case. The pt was reportedly covered in pox. Medical attention was sought. The pt was treated with acetaminophen (Tylenol) and colloidal oatmeal (Aveeno bath). No product quality complaint involved.  Additional information has been requested.  It was also reported that another pt had a similar experience (WAES0404USA02171).
Redness and swelling of vaccination site, left leg. (+) fever and abd. pain.
Cough that was like a bronchitis symptom also developed; Palpitations similar to those caused by excessive caffeine appeared (heart pounding or strong heart beats rather than arrhythmia); Pharyngeal streptococcal infection; Palpitations similar to those caused by excessive caffeine appeared (heart pounding or strong heart beats rather than arrhythmia); A pyrexia of 39 degrees C developed; This is a spontaneous report received from a contactable consumer (patient). A 47-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0161), via an unspecified route of administration in left arm on 07May2021 at 14:15 (at the age of 47 years old, not pregnant at the time of vaccination) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had known allergies to Zithromax. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: ER8727), via an unspecified route of administration in right arm on 16Apr2021 at 02:15 PM (at the age of 47 years old) for covid-19 immunisation and patient experienced no reaction. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. On 08May, the following day of the 2nd vaccination, a pyrexia of 39 degrees C developed. Then, from around 18May2021, palpitations similar to those caused by excessive caffeine appeared (heart pounding or strong heart beats rather than arrhythmia). She refrained from taking coffee or green tea for about 10 days, but they did not go away. They found a pharyngeal streptococcal infection on 18May2021. From around the 25May2021, cough that was like a bronchitis symptom also developed. So, she visited the Urgent Care Service on the 28May2021. Chest X-ray and electrocardiogram showed no abnormalities. COVID test was negative. The patient underwent lab tests and procedures which included body temperature: 36 degrees c centigrade on 10May2021, sars-cov-2 test (nasal swab): negative on 28May2021, chest x-ray: no abnormalities, electrocardiogram: no abnormalities. The events resulted in emergency room or doctor or other healthcare professional office/clinic visit. The patient did not received treatment due to the events. The outcome of events was recovered on an unspecified date in 2021.  Follow-Up (21Jul2021): Follow-up attempts are completed. No further information is expected.
first Moderna vaccine 3/24/21 but did not receive their second dose.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (first Moderna vaccine 3/24/21 but did not receive their second dose.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (first Moderna vaccine 3/24/21 but did not receive their second dose.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (first Moderna vaccine 3/24/21 but did not receive their second dose.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product was not provided. treatment medication was not provided.
Headache 1 hour after vaccine.  Concerned because son got vaccine at the same time and also developed headache.
Vaccinated 1996. Failed chicken pox vaccine. Chicken pox 01/17/01.